Molecular Biology Enzymes Market to Gain Huge Revenue Surge in Near Future


Posted January 29, 2021 by mmvaidya

The global molecular biology enzymes and kits & reagents market is projected to reach USD 13.60 Billion by 2022.
 
Molecular biology enzymes are natural proteins produced by living organisms (animals, plants, and bacteria) and are highly selective biochemical catalysts. Molecular biology reagents are chemicals used in molecular biology reactions to optimize the workflow.

The global Molecular Biology Enzymes Market is projected to reach USD 13.60 Billion by 2022 from USD 5.69 Billion in 2016, at a CAGR of 15.8% during the forecast period. Base year considered for the report is 2016. Forecast period considered for the report is 2017–2022.

Growth in the molecular biology enzymes and kits & reagents market is driven by factors such as increased research activities and R&D investments in the life science industry, rising number of genome projects, technological advancements in the life science industry, and rising incidence of infectious diseases & genetic disorders. However, limited reimbursements for genetic testing is expected to restrain the growth of this market during the forecast period.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=164131709

Objectives of the Study:

# To define and measure the global Molecular Biology Enzymes Market on the basis of product, application, end user, and region.

# To identify key micromarkets and their drivers within the global molecular biology enzymes and kits & reagents market, which are expected to offer impressive growth opportunities in the coming years.

# To identify trends and opportunities for stakeholders in the market and provide details of the competitive landscape for major market leaders.

# To provide detailed information regarding the major factors influencing market growth (drivers, restraints, challenges, and opportunities).

# To forecast the size of the market segments with respect to four main regions, namely, North America (US and Canada), Europe (Germany, UK, France, and Rest of Europe), Asia Pacific (China, Japan, India, and Rest of APAC), and the Rest of the World (Latin America and Middle East & Africa).

# To analyze the market structure and profile key players in the global molecular biology enzymes and kits & reagents market and comprehensively evaluate their core competencies.

# To track and analyze competitive landscape such as market share analysis and competitive leadership.

North America to dominate the market in 2017

In 2017, North America is expected to account for the largest share of the Molecular Biology Enzymes Market, followed by Europe, Asia Pacific (APAC), and the Rest of the World (Latin America and the Middle East & Africa). Factors such as increasing research funding for genomics research, rising number of pharmaceutical and biotechnology companies, favorable reimbursement scenario for molecular diagnostics, and growing prevalence of target indications are contributing to the large share of North America.

The molecular biology enzymes and kits & reagents market in several APAC countries, particularly, China, Japan, and India, are expected to witness high growth during the forecast period. This can be attributed to the increasing government interest in biomedical and biotechnology industries, outsourcing of clinical research activities to China, involvement of industry players in the Japanese market, growing pharmaceutical industry in India backed by government initiatives to drive market growth, and initiatives by non-profit organizations.

By end user, academic & research institutes to hold the largest market share in 2017

Based on end user, the Molecular Biology Enzymes Market is segmented into academic & research institutes, hospitals & diagnostic centers, pharmaceutical & biotechnology companies, and other end users (contract research organizations (CROs), food & beverage companies, and forensic agencies). The academic & research institutes segment is expected to command the largest share of the molecular biology enzymes and kits & reagents market in 2017. The large share of this segment can be attributed to the increasing research activities backed by funding from government and private organizations.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=164131709

Key Players:

The key players in the global Molecular Biology Enzymes Market are Thermo Fisher (US), Merck (Germany), Illumina (US), QIAGEN (Netherlands), New England Biolabs (US), Promega (US), Agilent (US), Roche (Switzerland), Takara Bio (Japan), Bio Basic (Canada), Jena Bioscience (Germany), and Molecular Biology Resources (US).

Target Audience:

# Molecular Biology Enzymes and Kits & Reagents Manufacturers and Vendors
# Associations Related to Molecular Biology Enzymes and Kits & Reagents
# Contract Research Organizations (CROs)
# Research Institutes and Academic Centers
# Pharmaceutical and Biopharmaceutical Companies
# Business Research and Consulting Service Providers
# Venture Capitalists

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Makarand Vaidya
Country United States
Categories Biotech , Industry , News
Tags molecular biology enzymes , molecular biology enzymes market
Last Updated January 29, 2021